What is NovoCure's price / book?

NovoCure (NVCR) reported price / book of 3.8× in Q1 2026.

How has NovoCure's price / book changed year-over-year?

NovoCure's price / book decreased by 30.7% year-over-year, from 5.4× to 3.8×.

What is the long-term trend for NovoCure's price / book?

Over 5 years (2020 to 2025), NovoCure's price / book has grown at a -35.4% compound annual growth rate (CAGR), from 37.7× to 4.3×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

NovoCure NVCR Price / book

Price / book at other companies

Boston ScientificBSX

3.6×-3.1×

MedtronicMDT

2.1×-0.1×

Iovance Biotherapeutics, Inc.IOVA

2×+0.6×

Nuvation BioNUVB

4.7×+3.2×

Vir Biotechnology, Inc.VIR

1.8×+0.9×

Syndax PharmaceuticalsSNDX

49.5×+44.6×

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.64B-36.7%

Enterprise value$1.59B-36.3%

P/S2.4×-1.7×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Calculated from NovoCure’s reported figures.

market cap/total stockholders equity=3.8×

Based on the most recent quarter.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's price / book?: NovoCure (NVCR) reported price / book of 3.8× in Q1 2026.
How has NovoCure's price / book changed year-over-year?: NovoCure's price / book decreased by 30.7% year-over-year, from 5.4× to 3.8×.
What is the long-term trend for NovoCure's price / book?: Over 5 years (2020 to 2025), NovoCure's price / book has grown at a -35.4% compound annual growth rate (CAGR), from 37.7× to 4.3×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.